Praxisnaher Leitfaden zum Vorgehen bei Hyponatriämie

Hyponatriämie - SIADH - Vasopressin-Rezeptor-Antagonist

Hyponatremia - SIADH - Vasopressin receptor antagonist

Literatur

• 1 Asadollahi K, Beeching N, Gill G. Hyponatremia as a risk factor for hospital mortality.  QJM. 2006;  99 877-80
• 2 Berl T, Quittnat-Pelletier F, Verbalis J G. et al . Oral tolvaptan is safe and effective in chronic hyponatremia.  J Am Soc Nephrol. 2010;  21 705-712
• 3 Ellison D H, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis.  N Engl J Med. 2007;  356 2064-2072
• 4 Fenske W, Maier S KG, Blechschmidt A et al. Utility and limitations oft the traditional diagnostic approach to hyponatremia.  Am J Med. 2010;  123 652-657
• 5 Fenske W, Störk S, Koschker A-C. et al . Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics.  J Clin Endocrinol Metab. 2008;  93 2991-2997
• 6 Gill G, Huda B, Boyd A. et al . Characteristics and mortality of severe hyponatraemia.  Clin Endocrinol (Oxf). 2006;  65 246-249
• 7 Hannon M J, Thompson C J. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences.  Eur J Endocrinol. 2010;  162 Suppl 1 S5-12
• 8 Renneboog B, Musch W. Mild chronic hyponatremia is associated with falls, unsteadiness and attention deficits.  Am J Med. 2006;  119 71.e1-8
• 9 Sandhu H S, Gilles E, DeVita M V et al. Hyponatremia is associated with large bone fracture in elderly patients.  Int Urol Nephrol. 2009;  41 733-737
• 10 Schrier R W, Gross P, Gheorghiade M. et al . Tolvaptan, a selective oral vasopressin V2-receptor antagonist for hyponatremia.  N Engl J Med. 2006;  355 2099-2112
• 11 Thompson C J, Crowley R K. Hyponatraemia.  J R Coll Physicians Edinb. 2009;  39 154-157
• 12 Upadhyay A, Jaber B L, Madias N E. Incidence and prevalence of hyponatremia.  Am J Med. 2006;  119 (Suppl 1) S30-35
• 13 Wald R, Jaber B, Price L et al. Impact of hospital-associated hyponatremia on selected outcomes.  Arch Intern Med. 2010;  170 294-302